High Tech Pharm Co Ltd
KOSDAQ:106190
Relative Value
The Relative Value of one High Tech Pharm Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 15 150 KRW, High Tech Pharm Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
High Tech Pharm Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
KR |
H
|
High Tech Pharm Co Ltd
KOSDAQ:106190
|
161.1B KRW | 2 | 13.9 | 8.4 | 11.4 | |
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
US |
Eli Lilly and Co
NYSE:LLY
|
767.8B USD | 21.4 | 125.1 | 61.2 | 69.6 | ||
DK |
Novo Nordisk A/S
CSE:NOVO B
|
4.1T DKK | 16.6 | 45.5 | 33.9 | 37.2 | ||
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | ||
US |
Johnson & Johnson
NYSE:JNJ
|
347.5B USD | 4.1 | 9 | 11.1 | 14.5 | ||
US |
Merck & Co Inc
NYSE:MRK
|
319.3B USD | 5.2 | 138.5 | 34.6 | 56.4 | ||
UK |
AstraZeneca PLC
LSE:AZN
|
185.9B GBP | 5 | 37.5 | 174.4 | 278.3 | ||
CH |
Roche Holding AG
SIX:ROG
|
182.5B CHF | 3.1 | 15.9 | 9 | 10.7 | ||
CH |
Novartis AG
SIX:NOVN
|
178B CHF | 3.3 | 11.1 | 8.5 | 12.4 | ||
US |
Pfizer Inc
NYSE:PFE
|
160.4B USD | 2.9 | -519 | 12.6 | 20.4 |